Related Experiment Videos
Superior adenoidectomy in children with palatal abnormalities
R S Kakani1, N D Callan, M M April
1Department of Surgery, State University of New York at Stony Brook, USA.
Ear, Nose, & Throat Journal
|April 29, 2000
Summary
Superior adenoidectomy effectively resolves nasal obstruction and otitis media in children with palatal abnormalities. This technique avoids velopharyngeal insufficiency, offering a safe surgical option for these complex cases.
Area of Science:
- Otolaryngology
- Pediatric Surgery
- Speech-Language Pathology
Background:
- Children with palatal abnormalities often require adenoidectomy for otitis media or nasal obstruction.
- A key concern is the risk of velopharyngeal insufficiency (VPI) following adenoidectomy.
- Treatment options include complete adenoidectomy, partial adenoidectomy, or non-surgical management.
Purpose of the Study:
- To evaluate the safety and efficacy of superior adenoidectomy in children with palatal abnormalities.
- To assess the incidence of VPI and recurrence of otitis media after superior adenoidectomy.
- To determine if superior adenoidectomy is a viable treatment option for these patients.
Main Methods:
- Retrospective study of 22 pediatric patients with palatal abnormalities undergoing superior adenoidectomy.
- Procedure performed using St. Clair adenoidforceps under indirect vision with a laryngeal mirror.
- Outcomes assessed included resolution of nasal obstruction, development of VPI, and recurrence of otitis media.
Main Results:
- Complete or near-complete resolution of nasal obstruction was observed in all patients.
- No patients developed permanent velopharyngeal insufficiency.
- Only three patients experienced a recurrence of otitis media.
Conclusions:
- Superior adenoidectomy is a safe and effective procedure for managing nasal obstruction and otitis media in children with palatal abnormalities.
- This surgical approach minimizes the risk of developing velopharyngeal insufficiency.
- Superior adenoidectomy presents a favorable risk-benefit profile for this patient population.